These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22166793)

  • 21. The effects of clinical motor variables and medication dosage on working memory in Parkinson's disease.
    Moustafa AA; Bell P; Eissa AM; Hewedi DH
    Brain Cogn; 2013 Jul; 82(2):137-45. PubMed ID: 23660434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulsivity across reactive, proactive and cognitive domains in Parkinson's disease on dopaminergic medication: Evidence for multiple domain impairment.
    Canário N; Sousa M; Moreira F; Duarte IC; Oliveira F; Januário C; Castelo-Branco M
    PLoS One; 2019; 14(2):e0210880. PubMed ID: 30759108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors underlying probabilistic and deterministic stimulus-response learning performance in medicated and unmedicated patients with Parkinson's disease.
    Moustafa AA; Krishna R; Eissa AM; Hewedi DH
    Neuropsychology; 2013 Jul; 27(4):498-510. PubMed ID: 23876122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
    Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
    Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    J Neurophysiol; 2010 Feb; 103(2):942-9. PubMed ID: 20018839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease.
    Cools R; Barker RA; Sahakian BJ; Robbins TW
    Neuropsychologia; 2003; 41(11):1431-41. PubMed ID: 12849761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor procedural learning in Parkinson's disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Brain; 2007 Nov; 130(Pt 11):2887-97. PubMed ID: 17855374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
    O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
    Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verbal fluency in Parkinson's disease patients on/off dopamine medication.
    Herrera E; Cuetos F; Ribacoba R
    Neuropsychologia; 2012 Dec; 50(14):3636-40. PubMed ID: 22995942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the Basal Ganglia network model markers for medication-induced impulsivity in Parkinson's disease patients.
    Balasubramani PP; Chakravarthy VS; Ali M; Ravindran B; Moustafa AA
    PLoS One; 2015; 10(6):e0127542. PubMed ID: 26042675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocognitive correlates of medication-induced addictive behaviours in Parkinson's disease: A systematic review.
    Dawson A; Dissanayaka NN; Evans A; Verdejo-Garcia A; Chong TTJ; Frazzitta G; Ferrazzoli D; Ortelli P; Yücel M; Carter A
    Eur Neuropsychopharmacol; 2018 May; 28(5):561-578. PubMed ID: 29653742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of dopamine agonists on adaptive and aberrant salience in Parkinson's disease.
    Nagy H; Levy-Gigi E; Somlai Z; Takáts A; Bereczki D; Kéri S
    Neuropsychopharmacology; 2012 Mar; 37(4):950-8. PubMed ID: 22089321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced motivation of cognitive control in Parkinson's disease.
    Timmer MHM; Aarts E; Esselink RAJ; Cools R
    Eur J Neurosci; 2018 Sep; 48(6):2374-2384. PubMed ID: 30151991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine selectively remediates 'model-based' reward learning: a computational approach.
    Sharp ME; Foerde K; Daw ND; Shohamy D
    Brain; 2016 Feb; 139(Pt 2):355-64. PubMed ID: 26685155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational Dissection of Dopamine Motor and Motivational Functions in Humans.
    Le Bouc R; Rigoux L; Schmidt L; Degos B; Welter ML; Vidailhet M; Daunizeau J; Pessiglione M
    J Neurosci; 2016 Jun; 36(25):6623-33. PubMed ID: 27335396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine enhances willingness to exert effort for reward in Parkinson's disease.
    Chong TT; Bonnelle V; Manohar S; Veromann KR; Muhammed K; Tofaris GK; Hu M; Husain M
    Cortex; 2015 Aug; 69():40-6. PubMed ID: 25967086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant dopamine transmission and cognitive dysfunction in animal models of Parkinson's disease.
    Lelos MJ; Dunnett SB
    J Parkinsons Dis; 2011; 1(2):151-65. PubMed ID: 23934917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.